KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Capital Expenditures (2017 - 2026)

Cardlytics filings provide 10 years of Capital Expenditures readings, the most recent being $28000.0 for Q1 2026.

  • Quarterly Capital Expenditures fell 76.47% to $28000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $15.2 million through Mar 2026, down 11.58% year-over-year, with the annual reading at $15.3 million for FY2025, 13.72% down from the prior year.
  • Capital Expenditures hit $28000.0 in Q1 2026 for Cardlytics, down from $15.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $16.3 million in Q4 2024 and bottomed at -$8.0 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $2.2 million, with a median of $659000.0 recorded in 2023.
  • Peak annual rise in Capital Expenditures hit 2933.83% in 2022, while the deepest fall reached 435.25% in 2022.
  • Cardlytics' Capital Expenditures stood at -$8.0 million in 2022, then skyrocketed by 108.34% to $667000.0 in 2023, then skyrocketed by 2343.33% to $16.3 million in 2024, then decreased by 6.97% to $15.2 million in 2025, then crashed by 99.82% to $28000.0 in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Capital Expenditures are $28000.0 (Q1 2026), $15.2 million (Q4 2025), and -$300000.0 (Q3 2025).